Â鶹app

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Â鶹app - Outstanding Awards (Details)

v3.21.2
Stock-Based Compensation - Â鶹app - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Additional disclosures Ìý
Total unrecognized compensation cost related to unvested equity awards | $ $ 64
Weighted average period of recognition related to unvested equity awards (in years) 2 years 1 month 6 days
Â鶹app SiriusXM Group Ìý
Number of options Ìý
Outstanding at end of period 0
Additional disclosures Ìý
Common stock reserved for issuance 11,000,000
Â鶹app SiriusXM Group | Common Class A Ìý
Number of options Ìý
Granted 0
Â鶹app SiriusXM Group | Common Class B Ìý
Number of options Ìý
Granted 0
Â鶹app SiriusXM Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 10,870,000
Granted 290,000
Exercised (172,000)
Outstanding at end of period 10,988,000
Exercisable at end of period 8,541,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 34.96
Granted | $ / shares 45.34
Exercised | $ / shares 31.64
Outstanding at end of period | $ / shares 35.28
Exercisable at end of period | $ / shares $ 32.65
Additional disclosures Ìý
Weighted average remaining life, outstanding 2 years 9 months 18 days
Weighted average remaining life, exercisable 1 year 10 months 24 days
Aggregate intrinsic value, outstanding | $ $ 123
Aggregate intrinsic value, exercisable | $ $ 117
Formula One Group Ìý
Number of options Ìý
Outstanding at end of period 1,000
WAEP Ìý
Exercised | $ / shares $ 12.63
Additional disclosures Ìý
Weighted average period of recognition related to unvested equity awards (in years) 1 year 6 months
Common stock reserved for issuance 11,100,000
Formula One Group | Common Class A Ìý
Number of options Ìý
Granted 0
Formula One Group | Common Class B Ìý
Number of options Ìý
Granted 0
Formula One Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 10,391,000
Granted 748,000
Exercised (54,000)
Outstanding at end of period 11,085,000
Exercisable at end of period 8,945,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 31.78
Granted | $ / shares 45.88
Exercised | $ / shares 21.18
Outstanding at end of period | $ / shares 32.78
Exercisable at end of period | $ / shares $ 30.46
Additional disclosures Ìý
Weighted average remaining life, outstanding 4 years 2 months 12 days
Weighted average remaining life, exercisable 3 years 8 months 12 days
Aggregate intrinsic value, outstanding | $ $ 171
Aggregate intrinsic value, exercisable | $ $ 159
Braves Group Ìý
Number of options Ìý
Outstanding at end of period 2,000
WAEP Ìý
Exercised | $ / shares $ 11.89
Additional disclosures Ìý
Weighted average period of recognition related to unvested equity awards (in years) 1 year
Common stock reserved for issuance 3,500,000
Braves Group | Common Class A Ìý
Number of options Ìý
Granted 0
Braves Group | Common Class B Ìý
Number of options Ìý
Granted 0
Braves Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 3,475,000
Granted 16,000
Exercised (9,000)
Outstanding at end of period 3,482,000
Exercisable at end of period 1,005,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 24.81
Granted | $ / shares 31.24
Exercised | $ / shares 16.94
Outstanding at end of period | $ / shares 24.86
Exercisable at end of period | $ / shares $ 19.04
Additional disclosures Ìý
Weighted average remaining life, outstanding 5 years 1 month 6 days
Weighted average remaining life, exercisable 2 years 2 months 12 days
Aggregate intrinsic value, outstanding | $ $ 11
Aggregate intrinsic value, exercisable | $ $ 9